In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis (Q24536041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

ChEBI release 2020-05-28

ChEBI ID

3887

Leishmania amazonensis

object named as

Leishmania amazonensis

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Leonardo Freire-de-Lima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Cerli R Gattass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Deise de Andrade Costa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Liwen He

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Martin E Kuehne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

2111-2115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

10 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Antileishmanial activity of an indole alkaloid from Peschiera australis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Treatment of acute opioid withdrawal with ibogaine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Leishmania-HIV interaction: immunopathogenic mechanisms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Ibogaine neurotoxicity: a re-evaluation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Ibogaine-like effects of noribogaine in rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Heyneanine Hydroxyindolenine, A New Indole Alkaloid from Ervatamia coronaria var. plena

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Ibogaine in acute opioid withdrawal. An open label case series

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Ervatamia coronaria: chemical constituents and some pharmacological activities.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Total synthesis of indole and dihydroindole alkaloids. IV. Total synthesis of dl-dihydrocleavamine, dl-carbomethoxydihydrocleavamine, dl-coronaridine, dl-dihydrocatharanthine, and dl-ibogamine. General entry into the iboga and vinca alkaloids

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127312

Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells

29 November 2018

1 reference

12 December 2020

Leishmaniaspp.: Mechanisms of Toxicity of Nitrogen Oxidation Products

1 reference

12 December 2020

Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells

1 reference

12 December 2020

Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha

1 reference

12 December 2020

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

12 December 2020

IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages

1 reference

12 December 2020

Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity

1 reference

12 December 2020

NMDA antagonist properties of the putative antiaddictive drug, ibogaine

1 reference

12 December 2020

Ibogaine and the dopaminergic response to nicotine

1 reference

https://api.crossref.org/works/10.1128%2FAAC.46.7.2111-2115.2002

7 January 2021

Pharmacology of Ibogaine and Ibogaine-Related Alkaloids

1 reference

https://api.crossref.org/works/10.1128%2FAAC.46.7.2111-2115.2002

7 January 2021

(±)-18-Methoxycoronaridine: A Novel Iboga Alkaloid Congener Having Potential Anti-Addictive Efficacy

1 reference

https://api.crossref.org/works/10.1128%2FAAC.46.7.2111-2115.2002

7 January 2021

Chemical Constituents and Pharmacological Activities of Peschiera australis

1 reference

https://api.crossref.org/works/10.1128%2FAAC.46.7.2111-2115.2002

7 January 2021

10.1128/AAC.46.7.2111-2115.2002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

12069962

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12069962%20AND%20SRC:MED&resulttype=core&format=json